Tuberculous Meningitis in a Patient with Crohn's Disease, Which was Treated with Infliximab / 대한소화기내시경학회지
Korean Journal of Gastrointestinal Endoscopy
;
: 339-342, 2007.
Artigo
em Coreano
| WPRIM
| ID: wpr-192073
ABSTRACT
Clinical trials of tumor necrosis factor (TNF) inhibitor have demonstrated significant efficacy in those patients with Crohn's disease that is not responsive to other anti-inflammatory drug. Infliximab is a human-murine chimeric monoclonal antibody with a high binding affinity and specificity for TNF-alpha. Yet therapy with infliximab is associated with an increased risk of opportunistic infection, and especially tuberculosis. Here we reported on a case of tuberculous meningitis in 26-year-old man, and he was treated with infliximab for uncontrolled and fistulous Crohn's disease. We also include a review of the literature.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Tuberculose
/
Tuberculose Meníngea
/
Infecções Oportunistas
/
Doença de Crohn
/
Sensibilidade e Especificidade
/
Fator de Necrose Tumoral alfa
/
Infliximab
Tipo de estudo:
Estudo diagnóstico
Limite:
Adulto
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Gastrointestinal Endoscopy
Ano de publicação:
2007
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS